Verve Therapeutics Market Cap

SHA:600141 has a market cap or net worth of 27.54 billion as of August 6, 2025. Its market cap has increased by 34.56% in one year.

Market Cap

27.54B

Enterprise Value

43.05B

Revenue

28.74B

Ranking

n/a

PE Ratio

18.63

Stock Price

$24.98

Market Cap Chart

Since September 5, 2001, SHA:600141's market cap has increased from 2.55B to 27.54B, an increase of 980.40%. That is a compound annual growth rate of 10.46%.

Market Cap History

Date	Market Cap	% Change
Aug 5, 2025	27.20B	13.59%
Dec 31, 2024	23.94B	18.00%
Dec 29, 2023	20.29B	-37.07%
Dec 30, 2022	32.24B	-23.45%
Dec 31, 2021	42.11B	241.07%
Dec 31, 2020	12.35B	16.81%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wanhua Chemical Group	190.71B
Baoshan Iron & Steel	158.08B
Shandong Gold Mining	133.00B
China Northern Rare Earth (Group) High-Tech Co.,Ltd	131.23B
Ningxia Baofeng Energy Group	113.96B
Inner Mongolia Baotou Steel Union	113.67B
Hengli Petrochemical	107.42B
Qinghai Salt Lake Industry Co.,Ltd	95.20B

Market Cap Rankings